| [1] Jafari M,Soltani M,Naahidi S,et al.Nonviral approach for targeted nucleic acid delivery[J].Curr Med Chem,2012,19(2): 197-208.[2] Jin L,Zeng X,Liu M,et al.Current progress in gene delivery technology based on chemical methods and nano-carriers[J].Theranostics,2014,4(3):240-255.[3] Bolhassani A,Javanzad S,Saleh T,et al.Polymeric nanoparticles: Potent vectors for vaccine delivery targeting cancer and infectious diseases[J].Hum Vaccin Immunother,2014,10(2):321-332.[4] Im GI.Nonviral gene transfer strategies to promote bone regeneration[J].J Biomed Mater Res A,2013,101(10):3009-3018.[5] Tiera MJ,Shi Q,Winnik FM,et al.Polycation-based gene therapy: current knowledge and new perspectives[J].Curr Gene Ther,2011,11(4):288-306.[6] Tosi G,Bortot B,Ruozi B,et al.Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier[J].Curr Med Chem,2013,20(17):2212-2225.[7] Hsu CY,Uluda? H.Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression[J].J Drug Target,2012,20(4):301-328.[8] Midoux P,Breuzard G,Gomez JP,et al.Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes[J].Curr Gene Ther,2008,8(5):335-352.[9] Taniyama Y,Azuma J,Kunugiza Y,et al.Therapeutic option of plasmid-DNA based gene transfer[J].Curr Top Med Chem,2012,12(15):1630-1637.[10] Sakharov DV,Jie AF,Filippov DV,et al.Binding and retention of polycationic peptides and dendrimers in the vascular wall[J].FEBS Lett,2003,537(1): 6-10.[11] Thomas M,Klibanov AM.Non-viral gene therapy: polycation-mediated DNA delivery[J].Appl Microbiol Biotechnol,2003,62(1):27-34.[12] Ogris M,Walker C,Blessing T,et al.Tumor-targeted gene therpy: strategies for the preparation of ligand-polythylene glycol-polythylenimine/DNA complexes[J].J Control Release,2003,91(1):173-181.[13] Kursa M,Walker GF,Roessler V,et al.Novel shielded transferrin-polyethylene-glycol- polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer[J].Bioconjug Chem,2003,14(1):222-231.[14] Islam MA,Firdous J,Choi YJ,et al.Regulation of endocytosis by non-viral vectors for efficient gene activity[J].J Biomed Nanotechnol,2014,10(1):67-80.[15] Kuo WT,Huang HY,Huang YY.Intracellular trafficking,metabolism and toxicity of current gene carriers[J].Curr Drug Metab,2009,10(8):885-894.[16] Won YW,Lim KS,Kim YH.Intracellular organelle-targeted non-viral gene delivery systems.[J].J Control Release,2011,152(1):99-109.[17] Paleos CM,Tziveleka LA,Sideratou Z,et al.Gene delivery using functional dendritic polymers[J].Expert Opin Drug Deliv,2009,6(1):27-38.[18] Lukacs GL,Haggie P,Lechardeur D,et al.Size-dependent DNA mobility in cytoplasm and nucleus[J].J Biol Chem,2000,275(3):1625-1629.[19] Suh J,Wirtz D,Hanes J.Efficient active transport of gene nanocarriers to the cell nucleus[J].Proc Natl Acad Sci,2003,100(7):3878-3882.[20] Vicent M,Guillem,Salvador FA.Transfection pathways of nonspecific and targeted PEI-polyplexes[J].Gene Ther Mol Biol,2004,8:369-384.[21] Brunner S,Sauer T,Carotta S,et al.Cell cycle dependence of gene transfer by lipoplex,polyplex and recombinant adenovirus[J].Gene Ther,2000,7(5):401-407.[22] Itaka K,Kataoka K.Recent development of nonviral gene delivery systems with virus-like structures and mechanisms[J].Eur J Pharm Biopharm,2009,71(3):475-483.[23] Kircheis R,Wightman L,Wagner E.Design and gene delivery activity of modified polyethylenimines[J].Adv Drug Deliv Rev,2001,53(3):341-358.[24] Bieber T,Meissner W,Kostin S,et al.Intracellular route and transcriptional competence of polyethylenimine-DNA complexes[J].J Control Release,2002,82(2): 441-454.[25] Adams GB,Chabner KT,Alley IR,et al.Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor[J].Nature,2006,439(7076):599-603.[26] McNeer NA,Schleifman EB,Glazer PM,et al.Polymer delivery systems for site-specific genome editing[J].J Control Release,2011,155(2):312-316.[27] Bilensoy E.Cationic nanoparticles for cancer therapy[J].Expert Opin Drug Deliv,2010,7(7):795-809.[28] Qin Z,Liu W,Li L,et al.Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers[J].Bioconjug Chem,2011,22(8):1503-1512.[29] Kunath K,von Harpe A,Fischer D,et al.Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency[J].J Control Release,2003,88(1):159-172.[30] Ogris M,Wagner E.Tumor-targeted gene transfer with DNA polyplexes[J].Somat Cell Mol Genet,2002,27(1-6):85-95.[31] Yoo HS,Jeong SY.Nuclear targeting of non-viral gene carriers using psoralen-nuclear localization signal (NLS) conjugates[J].Eur J Pharm Biopharm,2007,66(1): 28-33.[32] Yamashita YM,Jones DL,Fuller MT.Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome[J].Science,2003,301(5639):1547-1550.[33] Meneksedag-Erol D,Tang T,Uluda? H.Molecular modeling of polynucleotide complexes[J].Biomaterials,2014,35(25):7068-7076.[34] Biju V.Chemical modifications and bioconjugate reactions of nanomaterials for sensing,imaging,drug delivery and therapy[J].Chem Soc Rev,2014,43(3):744-764. |
